Ondansetron Orally Disintegrating Tablets (CAS-99614-02-5), imported in dosage form. The subject product, Ondansetron Orally Disintegrating Tablets, imported in 4 mg and 8 mg tablets, is a medicinal preparation containing Ondansetron, a serotonin 5-HT3 receptor antagonist, as the active ingredient. It is indicated for the prevention of nausea and vomiting associated with cytotoxic chemotherapy drugs, radiation therapy and surgery.
Please importantly note that only the relevant portion of the related US CUSTOMS RULING is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Ondansetron (CAS-99614-02-5) imported in dosage/tablet form. The subject product, Ondansetron is a medicinal preparation containing Ondansetron, a serotonin 5-HT3 receptor antagonist, as the active ingredient. It is indicated for the prevention of nausea and vomiting associated with both emetogenic cancer chemotherapy and radiation therapy.
Please importantly note that only the relevant portion of the related US CUSTOMS RULING is displayed above. You may refer to the said customs ruling for the entire ruling explanation.